PMID: 7537518May 1, 1995Paper

Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines

British Journal of Cancer
A L JackmanF T Boyle

Abstract

Four cell lines, the mouse L1210 leukaemia, the human W1L2 lymphoblastoid and two human ovarian (CH1 and 41M) cell lines, were made resistant to ZD1694 (Tomudex) by continual exposure to incremental doses of the drug. A 500-fold increase in thymidylate synthase (TS) activity is the primary mechanism of resistance to ZD1694 in the W1L2:RD1694 cell line, which is consequently highly cross-resistant to other folate-based TS inhibitors, including BW1843U89, LY231514 and AG337, but sensitive to antifolates with other enzyme targets. The CH1:RD1694 cell line is 14-fold resistant to ZD1694, largely accounted for by the 4.2-fold increase in TS activity. Cross-resistance was observed to other TS inhibitors, including 5-fluorodeoxyuridine (FdUrd). 41M:RD1694 cells, when exposed to 0.1 microM [3H]ZD1694, accumulated approximately 20-fold less 3H-labelled material over 24 h than the parental line. Data are consistent with this being the result of impaired transport of the drug via the reduced folate/methotrexate carrier. Resistance was therefore observed to methotrexate but not to CB3717, a compound known to use this transport mechanism poorly. The mouse L1210:RD1694 cell line does not accumulate ZD1694 or Methotrexate (MTX) polyglutamates...Continue Reading

Citations

Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B C GohE Douglass
Jun 10, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Anelisa K Coutinho, Caio M Rocha Lima
Jun 1, 2004·The Oncologist·Rongbao Zhao, I David Goldman
Jan 1, 1996·Journal of Cancer Research and Clinical Oncology·Y TakemuraA L Jackman
Jan 1, 1996·Investigational New Drugs·A L JackmanK R Harrap
Sep 9, 1999·Nucleosides & Nucleotides·J LiuW H Gmeiner
Apr 16, 2014·Nature Reviews. Clinical Oncology·Peter M WilsonRobert D Ladner
Mar 28, 1996·International Journal of Cancer. Journal International Du Cancer·Y TakemuraA L Jackman
Jan 15, 2004·Cancer Chemotherapy and Pharmacology·Joshua H BilenkerPeter J O'Dwyer
Jun 17, 2005·Cancer Science·Jee Hyun KimYung-Jue Bang
Jan 15, 1999·British Journal of Cancer·H L McLeod, G I Murray
Aug 1, 2005·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Myung-Ju AhnChan-Kum Park
Oct 25, 2003·Oncogene·Rongbao Zhao, I David Goldman
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thierry LecomtePierre Laurent-Puig
Feb 20, 2007·Molecular Cancer Therapeutics·Shrikanta ChattopadhyayI David Goldman
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maja J A de JongeJaap Verweij
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick G JohnstonCarmen J Allegra
Oct 6, 1999·Current Opinion in Immunology·K D BagshaweR J Knox
Apr 26, 2005·Bioorganic & Medicinal Chemistry·Youhoon ChongDale L Boger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
L R KellandA L Jackman
Annals of Oncology : Official Journal of the European Society for Medical Oncology
A L Jackman, A H Calvert
© 2021 Meta ULC. All rights reserved